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A B S T R A C T
Objectives: To evaluate the diagnostic value and characteristic features of FCD epileptogenic zones using a novel
sequence called ﬂuid and white matter suppression (FLAWS).
Materials and methods: Thirty-nine patients with pathologically conﬁrmed FCD and good surgery outcomes (class
I or II, according to the Engel Epilepsy Surgery Outcome Scale) were retrospectively included in the study. All
the patients underwent a preoperative whole-brain MRI examination that included conventional sequences
(T2WI, T1WI, two-dimensional (2D) axial, coronal ﬂuid-attenuated inversion recovery [FLAIR]) and FLAWS. An
additional 3D-FLAIR MRI sequence was performed in 17 patients. To evaluate the sensitivity and speciﬁcity of
FLAWS and investigate the cause of false-positives, 36 healthy volunteers were recruited as normal controls. Two
radiologists evaluated all the image data. The detection rates of the FCD epileptogenic zone on diﬀerent se-
quences were compared based on ﬁve criteria: abnormal cortical morphology (thickening, thinning, or abnor-
mally deep sulcus); abnormal cortical signal intensity; blurred gray-white matter junction; abnormal signal in-
tensity of the subcortical white matter, and the transmantle sign. The sensitivity and speciﬁcity of FLAWS for
detecting the FCD lesions were calculated with the reviewers blinded to all the clinical information, i.e. to the
patient identity and the location of the resected regions. To explore how many features were suﬃcient for the
diagnosis of the epileptogenic zones, the frequency of each criterion in the resected regions and their combi-
nations were assessed on FLAWS, according to the results of the assessment when the reviewers were aware of
the location of the resected regions. Based on the ﬁndings of the 17 patients with an additional 3D-FLAIR scan
when the reviewers were aware of the location of the resected regions, quantitative analysis of the regions of
interest was used to compare the tissue contrast among 2D-axial FLAIR, 3D-FLAIR, and the FLAWS sequence.
Visualization score analysis was used to evaluate the visualization of the ﬁve features on conventional, 3D-
FLAIR, and FLAWS images. Finally, to explore the reason for false-positive results, a further evaluation of the
whole brain FLAWS images was conducted for all the subjects.
Results: The sensitivity and speciﬁcity for detecting the FCD lesions on the FLAWS sequence were 71.9% and
71.1%, respectively. When the reviewers were blinded to the location of the resected regions, the detection rate
of the FLAWS sequence was signiﬁcantly higher than that of the conventional sequences (P=0.00). In the 17
patients who underwent an additional 3D FLAIR scan, no statistically signiﬁcant diﬀerence was found between
the FLAWS and the 3D-FLAIR (P= 0.25). All the patients had at least two imaging features, one of which was
“the blurred junction of the gray-white matter.” The transmantle sign, which is widely believed to be a speciﬁc
feature of FCD type II, could also be observed in type I on the FLAWS sequence. The relative tissue contrast of
FLAWS was higher than that of the 2D-FLAIR with respect to lesion/white matter (WM), deep gray matter (GM)/
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WM, and cortex/WM (P=0.00 for all three measures) and higher than that of the 3D-FLAIR with respect to the
lesion/WM (P=0.01). The visualization score analysis showed that the visualization of FLAWS was more en-
hanced than that of the conventional and 3D-FLAIR images with respect to the blurred junction (P= 0.00 for
both comparisons) and the abnormal signal intensity of the subcortical white matter (P= 0.01 for both com-
parisons). The thin-threadlike signal and individual FCD features outside the epileptogenic regions were con-
sidered the primary cause of the false-positive results of FLAWS.
Conclusions: FLAWS can help in the detection of FCD epileptogenic zones. It is recommended that epileptogenic
zone on FLAWS be diagnosed based on a combination of two features, one of which should be the “blurred
junction of the gray-white matter” in types I and II. In type III, the combination of “the blurred junction of the
gray-white matter” with “abnormal signal intensity of subcortical white matter” is recommended.
1. Introduction
Focal cortical dysplasia (FCD) is an underlying cause of seizures in
some patients. A complete resection of the epileptogenic zone is critical
for eliminating these seizures (Oluigbo et al., 2015; Rowland et al.,
2012). As a non-invasive imaging method with multi-contrasts, mag-
netic resonance imaging (MRI) plays an important role in pre-operative
epileptogenic zone localization. However, approximately 22–38% of
FCD patients have negative ﬁndings on conventional MRI (Kim et al.,
2011; Lerner et al., 2009). As the eﬀectiveness of identifying the epi-
leptogenic zones largely depends on the hardware (e.g., ﬁeld strength)
and software (e.g., MR sequences and post-processing methods) of MRI,
as well as the experience of the reader and the MR methods (Duncan
et al., 2016), improvements in these factors are needed.
In recent years, several new sequences, such as three-dimensional
ﬂuid-attenuated inversion recovery (3D FLAIR) (Saini et al., 2010;
Tschampa et al., 2015) and 3D double inversion recovery (3D-DIR)
(Soares et al., 2016; Wong-Kisiel et al., 2016), have been used to im-
prove the contrast of the cortex. However, the application of these se-
quences is limited due to several reasons. First, most studies currently
show the superiority of the new sequence through measuring quanti-
tative parameters, such as rating the visual score or measuring the
signal-to-noise ratio or tissue contrast, on diﬀerent types of images.
Consequently, they only choose visible lesions on the images. Because
the primary objective of applying novel sequences in epilepsy is to
improve the detection of epileptogenic zones (deﬁned as cortical areas
responsible for seizure generation) that cannot be identiﬁed using
conventional MRI, it is necessary to recruit patients with negative
ﬁndings on conventional MRI and with good surgery outcomes. Second,
although it is widely believed that ﬁve typical MRI features can help to
visually identify FCD on conventional sequences (Bernasconi et al.,
2011), including abnormalities of the cortex (abnormal cortical mor-
phology, signal increase on T2WI) and the subcortical white matter
(blurred junction of the gray-white matter, T2 signal increase, and
transmantle sign), there is only one study for type II FCD (Mellerio
et al., 2012), that has clearly stated how many features are suﬃcient for
the diagnosis of epileptogenic zones on MRI. Third, it may be diﬃcult to
identify lesions from false-positive results caused by the techniques
themselves, which have too high a sensitivity and a low speciﬁcity
(Duncan et al., 2016; Woermann and Vezina, 2013).
In this study, we applied in FCD a new sequence known as ﬂuid and
white matter suppression (FLAWS) (Tanner et al., 2012). This sequence
provides three diﬀerent high spatial resolution anatomical images in
one scan. First, FLAWS acquires two sets of 3D high spatial resolution
images at two diﬀerent inversion times (TI): TI1, which suppresses the
white-matter (WM) signal (WM-nulled image), and TI2, which sup-
presses the cerebrospinal ﬂuid (CSF) signal (CSF-nulled image). Sub-
sequently, a set of synthetic minimum FLAWS-contrast images is cal-
culated based on the two previously mentioned sets of images, and this
suppresses both the WM and CSF signals (gray-matter-speciﬁc). Because
FCD is caused by localized cortical disruptions of neuronal proliferation
and organization (Prayson et al., 2002; Taylor et al., 1971), the gray
matter-speciﬁc images have the potential to improve the visualization
of the FCD epileptogenic zones. To our knowledge, there is to date no
published research on the application of FLAWS in FCD. The purpose of
this study was to explore whether the FLAWS sequence could help in
the detection of FCD epileptogenic zones and to facilitate the applica-
tion of FLAWS in clinical practice.
2. Methods and materials
Thirty-nine patients with pathologically-conﬁrmed FCD were re-
cruited from our Xuanwu Hospital between October 2014 and July
2017 and retrospectively included in this study. Each patient had a
preoperative MRI examination including conventional and FLAWS
scans. Their surgical outcomes were categorized as class I or II, ac-
cording to the Engel Epilepsy Surgery Outcome Scale (Engel, 1993),
which were deﬁned as good surgery outcomes. An additional pre-op-
erative 3D-FLAIR scan was performed on 17 patients. This study was
approved by the Ethics Committee of Xuanwu hospital. Written in-
formed consent was obtained from each participant.
To evaluate the sensitivity and speciﬁcity of FLAWS and investigate
the cause of any misdiagnoses, healthy volunteers were recruited as
normal controls.
Table 1
Scan parameters for the FLAWS, 3D-FLAIR, and conventional sequences.
FLAWS 3D-FLAIR 2D-FLAIR 2D-FLAIR T1WI T2WI DWI
TR/TE (ms) 5000/2.88 6000/395 8500/85 8500/88 160/3.05 3800/93 5500/90
TI (ms) TI1/TI2 409/1100 2100 2371.5 2439
Flip angle (degree) FA1/FA2 5/5 T2 var 150 150 70 150 90
Matrix 256× 256 256×256 256×180 256×256 256×205 256×256 136×136
Slices thickness (mm) 1.0 1.0 3.0 3.0 3.0 3.0 3.0
BW (Hz/px) 310 781 287 201 360 219 1598
Orientation Sagittal Sagittal Axial Coronal Axial Axial Axial
FOV (mm) 256 250 240 230 240 240 240
iPAT 2 2 2 2 2 2 2
Scan time (sec) 657 422 114 104 38 36 40
2D, two-dimensional; 3D, three-dimensional; BW, band width; DWI, diﬀusion weighted imaging; FLAIR, ﬂuid-attenuated inversion recovery; FLAWS, ﬂuid and white
matter suppression; WM, white matter; FOV, ﬁeld of view; TE, echo time; TI, inversion time; TR, repetition time.
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2.1. Data acquisition
The imaging data of all the participants were collected using a
MAGNETOM Verio 3.0 T MR scanner (Siemens Healthcare, Erlangen,
Germany) with a 12-channel head-neck coil. All the patients underwent
conventional MRI protocols, including 2D axial and coronal FLAIR,
T2WI, T1WI, and DWI, in addition to FLAWS. Of the 39 recruited pa-
tients, an additional T2-SPACE-Dark-Fluid (3D-FLAIR) sequence was
applied to 17 patients who were admitted after March 2016. The scan
parameters of each sequence are listed in Table 1. The normal control
group only underwent FLAWS and 2D axial FLAIR scans. Their scan
parameters were consistent with those of the patient group.
2.2. Data analysis
Two experienced radiologists, with ten and thirteen years' experi-
ence, respectively, reviewed the images. Diﬀerences in assessments
between the radiologists were resolved by means of consensus. They
identiﬁed FCD epileptogenic zones according to the following ﬁve
imaging features (Bernasconi et al., 2011): (1) abnormal cortical mor-
phology, such as thickening or thinning, deﬁned as a thickening or
thinning of at least half of the normal cortex, or abnormal deep sulcus,
visible both on T1WI and T2WI sequences in at least two orthogonal
planes; (2) abnormal cortical signal intensity; (3) blurred junction of the
gray-white matter, deﬁned as visible on at least one sequence and in
two orthogonal planes; (4) abnormal signal intensity of subcortical
white matter; and (5) transmantle sign, deﬁned as a subcortical funnel-
shaped white matter signal intensity change, tapering toward the ven-
tricle (Fig. 1). Among the three types of FLAWS images (WM-nulled,
CSF-nulled, and FLAWS contrast image), we only evaluated the detec-
tion ability of the FLAWS-contrast image as it is a gray-matter-speciﬁc
contrast image. The surgically resected regions were considered as the
site of the epileptogenic zones and the gold standard of the comparison
among sequences, as all the patients had good surgery outcomes.
The evaluation of FLAWS was performed in four steps. Because
clinical information obtained from a former step could aﬀect the latter
step, the four steps were conducted in the following order. In steps 1
and 2, we referred to the positive criteria of a previous study (Mellerio
et al., 2012); images presenting with at least one of the above ﬁve
characteristics were considered to be positive for FCD:
Step 1: Two reviewers determined whether the image had an
abnormal appearance and where lesions were located on FLAWS
performed on all the subjects (patients and normal controls). The
sensitivity, speciﬁcity, positive predictive value, negative predictive
value, likelihood ratio positive, and likelihood ratio negative were
calculated.
Step 2: To compare the detection rates of diﬀerent types of MRI
scans, reviewers identiﬁed FCD lesions in all the patients. In this
step, the overall conventional ﬁnding was considered to be positive
if any type of the conventional images (2D FLAIR/T2WI/T1WI
images) had a positive ﬁnding. The comparison was performed
twice.
First, the reviewers were blinded to the location of the resected
regions but were aware of any clinical information such as symp-
toms, preoperative electroencephalography (EEG), and magne-
toencephalography, simulating the preoperative assessment in
clinical practice.
Second, the reviewers were aware of the location of the resected
regions. Based on the results of the second assessment, a further
evaluation about the frequency of each feature in the resected re-
gions and their combination were applied on the FLAWS-contrast
images. Moreover, quantitative comparisons were performed in the
17 patients who also underwent a 3D-FLAIR scan: (1) each feature in
the resected regions on conventional, 3D-FLAIR, and FLAWS images
was rated on a 3-point visualization scale from 0 (no diﬀerence) to 2
(marked diﬀerence), compared with the contralateral normal ap-
pearing side, under the condition that the reviewers were aware of
the location of the resected regions. The visualization scores of the
ﬁve features on the three kinds of images were compared; (2) We
also quantitatively compared perceived the relative contrast be-
tween diﬀerent tissues on 2D-axial FLAIR, 3D-FLAIR, and FLAWS
images in these 17 patients. The contrast-to-noise ratio (CNR) was
measured because the standard deviation of the inhomogeneous air
signal outside the object could not be used for the noise in the CNR
estimation on parallel imaging (Stehling et al., 2007; Tschampa
et al., 2015) such as 3D-FLAIR and FLAWS. We only chose axial
rather than coronal FLAIR in 2D FLAIR, as the scanning range of the
coronal 2D FLAIR for epilepsy in our hospital is conﬁned to the
hippocampus, whereas that of the axial 2D FLAIR encompasses the
entire brain. The perceived relative contrast between diﬀerent tis-
sues was calculated to compare the sequences using the following
formula: (mean signal A− mean signal B)/ (mean signal A + mean
signal B) (Morakkabati-Spitz et al., 2006), where A represents the
Fig. 1. Sample graphs of ﬁve FCD features on the 2D axial FLAIR (A) and the FLAWS contrast image (B).
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signal intensity of tissue A, and B represents the signal intensity of
tissue B. We deﬁned the corpus callosum (genu) for the white
matter, caudate nucleus (head) for deep gray matter, and cortex
contralateral to the lesion for normal cortex. The lesion was mea-
sured based on the ﬁndings when reviewers were aware of the lo-
cation of the resected regions. The region of interest (ROI) was
manually drawn and saved on the FLAWS-contrast image. Three
measurements were performed per anatomical site, and the mean
values of the ROI measurements were subsequently used. To com-
pare diﬀerent types of images in the same slice, both 3D-FLAIR and
2D-axial FLAIR images were co-registered to the FLAWS-contrast
image using SPM12 of MATLAB, and the same ROIs that had been
saved on the FLAWS-contrast image were used in the two types of
images.
Step 3: To investigate the reason for false-positive ﬁndings, a further
reading of the FLAWS images in all the subjects was conducted by
the reviewers, when they were aware of who the patients were and
where the resected regions were located. If there were some signals
like the FCD features, their relationship with age, sex, and location
would be explored. In addition, their morphological diﬀerences with
FCD features would be compared by rating them on a 3-point vi-
sualization scale from 0 (no diﬀerence) to 2 (marked diﬀerence).
Step 4: To establish and optimize the diagnostic criteria of FCD on
FLAWS-contrast images, the frequency of the features in the resected
regions and the false-positive ﬁndings were comprehensively con-
sidered together to determine how many features were suﬃcient for
the diagnosis of any epileptogenic zones.
2.3. Statistical methods
Statistical analyses were performed using SPSS 18.0 for Windows
(SPSS Inc., Chicago, IL, USA). For statistical comparisons of in-
dependent data, the Fisher's exact test was performed. For comparisons
of paired binary data, the McNemar test was performed, and for com-
parisons of multiple data, the Friedman test was conducted. P < 0.05
was regarded as being statistically signiﬁcant. If the result of the
Friedman test was statistically signiﬁcant, a post hoc analysis with
Wilcoxon signed-rank tests was conducted with a Bonferroni correction
applied, with a new signiﬁcance level of 0.05/3≈ 0.02.
3. Results
The detailed clinical proﬁles of the patients are summarized in
Table 2. Thirty-nine patients (24 male; mean age, 23.3 ± 8.8 years;
age range, 8–48 years) were enrolled. According to the Blümcke clas-
siﬁcation (Blümcke et al., 2011), 21 cases were FCD type I, 11 were FCD
Table 2
The clinical proﬁles of the FCD patients and their MRI visual evaluation results.
No Sex Age (years) Course (years) Engle scale Follow-up (years) Conventionala MRI 3D FLAIRa FLAWS Resection areas FCD type
Blinded Unblinded
1 M 29 17 I 3 − NA + + R Front Ib
2 F 17 17 I 2.5 − NA + + R Hipp & Temp IIa
3 F 18 7 I 2.4 − NA + + R Temp & Ins Ib
4 M 27 17 I 2.3 + NA + + L Front Ib
5 M 27 6 I 1.6 − − + + L Hipp & Temp Ia
6 M 11 10 II 1.7 − NA + + R Hipp & Temp & Front Ia
7 M 21 5 II 2 − NA + + R Front IIa
8 M 24 21 I 2.7 + NA + + L Front IIa
9 M 16 7 I 1.6 + + + + L Pari IIb
10 M 8 6 II 1.5 − − − + L Temp & Occi & Pari Ia
11 M 29 24 I 1.5 + + + + R Temp & Front Ic
12 M 34 14 I 2.5 − NA − + L Hipp & Temp IIIa
13 F 8 1 II 3 + NA + + R Temp & Occi Ib
14 M 48 16 I 1.7 − + + + L Front Ic
15 M 23 6 I 1.9 + + + + L Hipp & Temp Ia
16 F 24 2 II 2.4 − NA + + R Hipp & Temp Ia
17 M 24 10 I 2.4 − NA − − L Hipp & Temp Ia
18 F 25 13 I 2.5 − NA − − L Hipp & Temp & Front Ia
19 F 38 37 I 2.3 + NA + + R Front IIb
20 F 42 30 I 1.1 − − − + R Pari Ia
21 M 10 4 I 1.4 − NA + + R Front Ib
22 F 19 8 I 1.3 − − − + L Temp & Occi Ic
23 F 23 10 I 2.8 + NA + + R Hipp & Temp IIa
24 M 26 14 I 1.1 − + + + R Front IIa
25 M 12 2 I 2.5 + NA + + R Front IIb
26 M 20 8 I 2.4 + NA + + R Hipp & Temp IIb
27 F 25 19 I 3.2 + NA + + L Front IIb
28 F 19 14 I 2.4 + NA + + R Hipp & Temp IIIa
29 M 29 14 I 2 − − − − L Hipp & Temp IIIa
30 M 34 30 I 1.9 + + + + L Hipp & Temp IIIa
31 M 17 10 II 1.5 − − − − R Temp Ia
32 M 13 8 II 0.5 + + + + R Pari IIIa
33 M 19 12 I 0.3 − − + + L Hipp & Temp & Front Ib
34 F 23 10 I 0.3 − − − − L Temp & Occi & Pari Ib
35 F 23 21 I 0.3 − − + + R Hipp & Temp IIIa
36 F 25 17 II 2.7 − NA − − L Temp & Occi & Pari Ia
37 M 20 17 II 2 − NA − + R Front Ia
38 F 25 5 I 2.6 − NA + + R Front IIa
39 M 35 6 II 1.1 + + + + R Hipp & Temp IIIb
a The results were same whether the reviewers were blinded to the location of the resection regions or not; Blinded, the reviewers were blinded to the location of
the resection regions; Unblinded, the reviewers were not blinded to the location of the resection regions; F, female; FCD, frontal cortical dysplasia; Front, frontal lobe;
Hipp, hippocampus; Ins, insula; L, left; M, male; Occi, occipital lobe; Pari, parietal lobe; R, right; Temp, temporal lobe; +, positive;−, negative; NA, not applicable.
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type II, and 7 were FCD type III. Thirty-ﬁve had more than one-year
postoperative follow-up, whereas the remaining four had less than six-
month follow-up. A total of 36 normal controls (20 men; mean age,
24.8 ± 7.5 years; age range, 10–50 years) were enrolled. No structural
abnormality was found on 2D axial FLAIR in this group. No signiﬁcant
diﬀerences were observed with respect to sex (P=0.56) or age
(P= 0.27) between the patients and normal controls. In addition, none
had any previous neurological disease.
3.1. The operation of FLAWS when the reviewers were blinded to any
information
The numbers of true positives, false-positives, true negatives, and
false-negatives were 23 (13 had positive conventional MRI results), 11
(7 were patients), 27, and 9, respectively. The sensitivity, speciﬁcity,
positive predictive value, negative predictive value, likelihood ratio
positive, and likelihood ratio negative were 71.9%, 71.1%, 67.6%,
75.0%, 2.48, and 0.40, respectively.
3.2. The detection rates of diﬀerent types of MRI scans in patients
Among the 39 patients, 24 had negative ﬁndings on the conven-
tional images when the reviewers were blinded to the location of the
resected regions; of these, 17 were FCD type I, 4 FCD type II, and 3 FCD
type III. In addition, of the 24 patients, 13 negative ﬁndings were po-
sitive on FLAWS, 8 of whom were FCD type I, 4 FCD type II, and 1 FCD
type III. The detection rate of FLAWS was signiﬁcantly higher than that
of the conventional sequences (P= 0.00). When the reviewers were
aware of the location of the resected regions, no additional lesions
could be detected on the conventional images, whereas ﬁve more ne-
gative ﬁndings were positive on FLAWS, 4 of whom were FCD type I
and 1 FCD type III.
Among the 17 patients who additionally underwent the 3D-FLAIR
scan, 9 patients had negative ﬁndings when the reviewers were blinded
to the location of the resected regions; 7 were FCD type I and 2 FCD
type III. Of the 9 patients, 3 negative ﬁndings were positive on FLAWS,
2 of whom were FCD type I and 1 FCD type III (Figs. 2 and 3). However,
no statistically signiﬁcant diﬀerence was found between FLAWS and
3D-FLAIR (P=0.25). When the reviewers were aware of the location of
the resected regions, no additional lesions could be detected on the 3D-
FLAIR whereas three more negative ﬁndings were positive on FLAWS,
all FCD type I.
The visualization score analysis showed the following: (1) there
were no signiﬁcant diﬀerences among FLAWS, 3D-FLAIR, or the con-
ventional images with respect to abnormal cortical morphology
(P= 0.42) and abnormal cortical signal intensity (P=0.85); (2) the
visualization of FLAWS was more enhanced than that of the conven-
tional and 3D-FLAIR images with respect to the blurred junction
(P= 0.00 for both comparisons) and the abnormal signal intensity of
the subcortical white matter (P=0.01 for both comparisons); (3) al-
though there was a diﬀerence among FLAWS, 3D-FLAIR, and the con-
ventional images with respect to the transmantle sign (P= 0.04)
(Fig. 2B, Table S1), no statistical diﬀerence was found between any two
of the studies (P=0.05 for FLAWS vs. 3D-FLAIR, and P= 0.06 for
FLAWS vs. conventional images).
When measuring the tissue contrast, 14 of the 17 patients had po-
sitive lesions on the FLAWS-contrast images when the reviewers were
aware of the location of the resected regions. There was no signiﬁcant
diﬀerence between the 2D versus 3D FLAIR sequences (P > 0.02). The
relative tissue contrast of FLAWS was higher than that of the 2D with
respect to lesion/WM, deep gray matter (GM)/WM, and cortex/WM
(P=0.00 for all three) and higher than that of 3D FLAIR with respect
to lesion/WM (P=0.01) (Table 3).
3.3. Five FCD features on FLAWS images in the epileptogenic zones
In patients with positive ﬁndings on FLAWS when the reviewers
were aware of the location of resected regions (n= 33), 16 were FCD
type I, 11 were FCD type II, and 6 were FCD type III. All the patients
had at least two features, one of which was “the blurred junction of the
gray-white matter.” In addition, the transmantle sign could be detected
in 16 of the 39 patients, and it was not limited to type II patients
(Figs. 2A, 4, and 5).
3.4. Reasons for false-positives
In all the normal controls and patients, more than one thin-
threadlike signal could be detected in the subcortical white matter on
FLAWS, but not on FLAIR. It appeared alone without any other kinds of
abnormal signals in the surrounding area. Its morphological char-
acteristics could easily be confused with the transmantle sign. Both
extended from the ventricle to the cortex, exhibiting a hypointense
signal on the CSF-nulled image and a hyperintense signal on the WM-
nulled and FLAWS contrast images (Fig. 6). The degrees of thickness,
length, and clarity between the thin-threadlike signal and the trans-
mantle sign were not signiﬁcantly diﬀerent (P > 0.05). No correlation
Fig. 2. Epileptogenic lesions on 3D-FLAIR and
FLAWS. In patient No. 9 (FCD type IIb), the le-
sion, including “the transmantle sign” (arrow),
“thickening cortex,” and “blurred junction of the
gray-white matter,” is more visible on the
FLAWS than the 3D-FLAIR image (A). In patient
No.22 (FCD type Ic), the lesion, including “the
transmantle sign” (arrow) and “abnormal signal
intensity of subcortical white matter,” could be
found on the FLAWS image, not on the 3D-
FLAIR image (B).
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Fig. 3. Patients with 3D-FLAIR-negative but FLAWS-positive ﬁndings. The decreased volume of the hippocampus (A and C) or temporal horn (B) could be detected on
both 3D-FLAIR and FLAWS but was more obvious on 3D-FLAIR. However, FCD features, including “blurred junction of the gray-white matter” and “abnormal signal
intensity of subcortical white matter,” could only be observed on FLAWS in their epileptogenic lesions. In patient No.5 (FCD type Ia), the epileptogenic lesion was in
the left hippocampus and temporal lobe (A). In patient No.33 (FCD type Ib), the epileptogenic lesion was in the left hippocampus, temporal lobe, and frontal lobe (B).
In patient No.35 (FCD type IIIa), the epileptogenic lesion was in the right hippocampus and temporal lobe (C).
Table 3
The quantitatively comparison of perceived relative contrast in 14 patients with positive lesions on FLAWS when reviewers were aware of the location of the
resection regions.
Sequence P⁎ P⁎⁎ for post hoc
2D FLAIR 3D FLAIR FLAWS 2D vs 3D FLAIR 2D FLAIR vs FLAWS 3D FLAIR vs FLAWS
Lesion/WM 0.07 ± 0.22 0.05 ± 0.10 0.21 ± 0.13 0.02 0.38 0.01 0.00
Deep GM/WM 0.08 ± 0.19 0.09 ± 0.05 0.31 ± 0.10 0.00 0.25 0.00 0.00
Cortex/WM 0.13 ± 0.24 0.08 ± 0.10 0.27 ± 0.11 0.00 0.29 0.05 0.00
⁎ P < 0.05 was considered signiﬁcant (two-tailed).
⁎⁎ P < 0.02 was considered signiﬁcant (one-tailed). WM, white matter; GM, gray matter.
Fig. 4. Patient No.26 (FCD type IIb) (A) and patient No.3 (FCD type Ib) (B). The ﬁrst column shows the MEG results which are consistent with the resected regions;
the following three columns show the “transmantle sign” in the epileptogenic lesion, the thin-threadlike signal, and individual FCD features outside the epileptogenic
regions on the FLAWS contrast image, respectively.
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was observed between the thin-threadlike signal and the transmantle
sign with respect to sex, age, or location in both the patients and normal
controls (P > 0.05).
In the patients, individual FCD features could occasionally be found
outside the epileptogenic regions, contralateral or ipsilateral to the
epileptogenic zone (Fig. 4).
3.5. Tailored visual criteria for FLAWS
To minimize the false-positive ﬁndings when recalculating the fre-
quency of each feature and their combination in the epileptogenic le-
sions, the transmantle sign was excluded and the epileptogenic lesions
were required to have more than two of the other four features.
The most frequent feature was “the blurred junction of the gray-
white matter” in both types I and II. This was accompanied by any of
the other three features in 100% type I and 90.9% II patients. In type III,
“the blurred junction of the gray-white matter” with “abnormal signal
intensity of the subcortical white matter” was the only combination
seen (71.4%).
4. Discussion
The primary ﬁndings of the FLAWS sequence in patients with his-
tologically-conﬁrmed FCD and good surgery outcomes were as follows:
(1) the detection rate of the FLAWS sequence was higher than that of
conventional sequences and 3D-FLAIR; (2) all three FCD types had at
least two features on FLAWS, one of which was “blurred junction of the
gray-white matter;” (3) false-positive results were primarily caused by
the thin-threadlike signal and individual FCD feature outside the epi-
leptogenic regions; and (4) the transmantle sign was not a speciﬁc
criterion of FCD type II on FLAWS.
4.1. The feasibility of FLAWS for clinical application in FCD
Based on the MP2RAGE sequence, the FLAWS sequence acquires
two gradient echo readout trains at TI1 and TI2 in one acquisition
(Marques et al., 2010). Tanner and colleagues (Tanner et al., 2012)
reported that the MP2RAGE sequence can generate two images at a TI1
of 409ms and TI2 of 1100ms on a 3 T MR scanner, including one WM-
Fig. 5. Five criteria in three FCD types on the FLAWS images. Letters A to E correspond to ﬁve FCD criteria, respectively. The outer ring shows the combination
patterns of the ﬁve criteria and the number of patterns.
Fig. 6. The thin-threadlike signal (arrow) in a 28-year-old female normal control (A) and a 16-year-old male FCD type II patient (B), respectively. The thin-threadlike
signal is invisible on the FLAIR and visible on the FLAWS images. The arrow head points to the epileptogenic zone of the patient.
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nulled image and one CSF-nulled image. They also proposed a
minimum intensity projection between the two contrasts (FLAWS
contrast image), resulting in a gray-matter speciﬁc image. To our
knowledge, the FLAWS sequence has been previously used once as an
experimental sequence in ﬁve healthy volunteers for future application
in deep brain stimulation placement (Tanner et al., 2012). The present
study is the ﬁrst that investigated the FLAWS sequence in patients with
FCD.
The improved visualization of epileptogenic zones on FLAWS is
primarily due to the following factors: (1) gray matter-speciﬁc contrast
is suitable for displaying the predominant histopathological abnorm-
alities in subtle epileptogenic zones, including altered cortical organi-
zation and cytological anomalies at the bottom of the sulcus
(Bernasconi et al., 2011; Blümcke et al., 2011). It is consistent with our
results that the most common feature of FCD was “blurred junction of
the gray-white matter;” (2) the 1-mm isotropic voxel size can increase
the spatial resolution and reduce partial volume eﬀects (Kokkinos et al.,
2017); (3) the epileptogenic zones at the bottom of the sulcus, which
cannot be detected in the 2D images, can be displayed well by using
multi-planar reformatting of 3D images. According to our results, some
epileptogenic lesions, which cannot be identiﬁed on conventional MRI
or even on 3D-FLAIR images, could be detected on the FLAWS images.
This may provide surgical opportunities for more patients, particularly
for type I patients who are more likely to have negative MR results
(Bernasconi et al., 2011; Seo et al., 2011).
One disadvantage of FLAWS is that its acquisition time is longer
than that of both the conventional and 3D-FLAIR sequences. The basic
protocol for patients with epilepsy, established by the International
League Against Epilepsy (1997), includes whole-brain T1WI/T2WI with
the minimum slice thickness possible in two orthogonal planes and a
volumetric (1 mm isotropic voxels) 3D-T1WI. The total acquisition time
to complete the basic protocol is the same or greater than that of
FLAWS. This suggests that FLAWS may be useful for some clinical ap-
plications.
4.2. Reasons for false-positive and false-negative results and the
interpretation criteria for FCD epileptogenic zone on FLAWS
False-positive results are primarily caused by the thin-threadlike
signal and individual FCD features outside the epileptogenic regions,
for the following reasons:
(1) The morphological characteristics of the thin-threadlike signal can
be confused with the transmantle sign. Based on its morphological
and signal characteristics, the thin-threadlike signal may be most
likely type II Virchow-Robin (VR) spaces (Kwee and Kwee, 2007;
Tsutsumi et al., 2011). Although small VR spaces (< 2mm) can
appear in all age groups, their visualization using MRI is dependent
on the applied imaging technique (Pantoni et al., 2005). Higher
signal-to-noise ratios (SNR) at higher magnetic ﬁeld strengths,
which are all advantages of the FLAWS sequence (high resolution,
thin-slice, multi-planar reformatting), can also improve the visua-
lization of the VR spaces. In the FCD epileptogenic zones, the thin-
threadlike signal could be distinguished from the transmantle sign,
as the thin-threadlike signal appears alone whereas the transmantle
sign in the epileptogenic zone was always accompanied by at least
one of the other four FCD features on FLAWS. However, outside the
epileptogenic zone, it is diﬃcult to distinguish them as the trans-
mantle sign could also appear alone;
(2) The clinical signiﬁcance of individual FCD features outside the
epileptogenic regions is unclear. According to previous structural
MRI studies, diﬀuse structural changes can be found outside the
epileptogenic regions, suggesting an anatomical and functional
network mechanism linked to the epileptogenic zone (Bonilha et al.,
2006; Colliot et al., 2006; Doucet et al., 2015; Keller et al., 2002) or
occult dysplastic epileptogenic zones (Najm et al., 2013; Prayson
et al., 2002; Rugg-Gunn et al., 2006). The fact that our patients had
good outcomes supports the notion that the individual FCD features
outside the epileptogenic regions are a component of the epilepsy
network rather than the epileptogenic zone. Although the role of
features in the epileptogenic zones and individual FCD features
outside the epileptogenic zones are diﬀerent, their morphological
characters might be the same. Thus, individual FCD features outside
the epileptogenic zones cannot be distinguished from those in the
epileptogenic zones on FLAWS; if we continue to follow the pre-
vious criteria, that ﬁnding is positive, provided any one of the ﬁve
features is present.
False-negative results are primarily caused by insuﬃcient clinical
information (subjective factor) and limitations of the current FLAWS
technology (objective factor). The subjective factor is supported by the
fact that some negative lesions on FLAWS in the simulated preoperative
assessment were positive when the reviewers were aware of the loca-
tion of the resection regions. The limitations of the current FLAWS
technology may be the reason that there were some lesions that could
not be found or detected, even when the reviewers were aware of the
location of the resected regions. Improvements in the MR hardware
technology, such as higher-ﬁeld magnets at> 3 T, combined with the
use of head coils with more phased arrays, may be helpful (Bernasconi
et al., 2011; Duncan et al., 2016).
Overall, to minimize false-positives caused by the thin-threadlike
signal and the individual FCD feature outside the epileptogenic regions,
a tailored criterion is proposed, namely, that the interpretation should
be performed in the context of clinical information, which can guide the
reviewers to ﬁnd lesions in the most likely places to improve the de-
tection rate, and diagnosis of the epileptogenic lesions should be based
on a combination of two features, one of which is “the blurred junction
of the gray-white matter.”
4.3. The transmantle sign was not speciﬁc for FCD type II on FLAWS
One notable ﬁnding of our study was that the transmantle sign was
not speciﬁc for FCD type II on FLAWS. We determined that subcortical
funnel-shaped signals in the epileptogenic zone signiﬁed the trans-
mantle sign rather than the thin-threadlike signal or some other
structure; the thin-threadlike signal appeared alone, whereas at least
two features could be found in the epileptogenic zones.
The high-resolution, thin-slice (1.0 mm) and multi-planar re-
formatting of the FLAWS sequence can help radiologists identify the
transmantle sign (Kokkinos et al., 2017). According to our ﬁndings, the
transmantle sign could be seen in types I and II on FLAWS, which is not
consistent with previous studies demonstrating that the transmantle
sign on conventional sequences is speciﬁc to FCD type II (Kaido et al.,
2012; Kokkinos et al., 2017; Muhlebner et al., 2012; Sakakibara et al.,
2012). This ﬁnding may expand our understanding of the imaging
criteria and corresponding pathological basis of FCD. According to the
Blümcke classiﬁcation (Blümcke et al., 2011), neocortical dyslamina-
tion exists in both types I and II, whereas dysmorphic neurons and
balloon cells only exist in FCD types IIa and IIb, respectively. Because
the transmantle sign can be found in both types I and II, its pathology is
more likely related to abnormal cortical layers than to dysmorphic
neurons and balloon cells. This inference is supported by a pathology-
based study that demonstrated that various layer-speciﬁc markers were
abnormally present and continuously distributed in the neurons of the
transmantle dysplasia epileptogenic zone (Sakakibara et al., 2012) and
by a clinical retrospective study showing the transmantle sign in a
patient with FCD type I (Wang et al., 2013a). Because the presence of
the transmantle sign is associated with highly favorable seizure out-
comes (Wang et al., 2013a, b), its enhanced visualization may improve
the process for selection of candidates for surgery.
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4.4. Limitations
There are several limitations in our study. First, it was retrospective
and was only based on patients who underwent surgeries that had a
good outcome, which does not represent the entire spectrum of FCD.
However, a study on the detection of the epileptogenic zone would be
limited if patients do not have histological conﬁrmation and post-
operative follow-up. Future studies should continue to retrospectively
recruit patients with histological conﬁrmation but poor outcome to
explore whether the ﬁve features have any diﬀerences in their mor-
phological characteristics, frequency, or a combination. Second, the
small sample size of patients with the 3D-FLAIR scan may be the reason
for the lack of a statistically signiﬁcant diﬀerence between FLAWS and
3D-FLAIR. Further studies with larger sample sizes should therefore be
conducted. Third, the positive MRI ﬁndings were only based on con-
ventional visual analysis. Automatic quantitative analysis, such as
voxel-based morphometry, would possibly further increase the detec-
tion rate (Wang et al., 2016). Unfortunately, the post-processing
methods have not been used in routine practice and their interpretation
still requires experienced readers (Wang and Alexopoulos, 2016). Fi-
nally, future studies should compare the FLAWS sequence to other
advanced sequences, such as the double inversion recovery sequence
(Wong-Kisiel et al., 2016), in which both the CSF and WM signals can
be suppressed. Even if the detection rates of the two sequences are si-
milar, the advantage of producing three perfectly registering, 3D high
spatial resolution structural images makes the FLAWS sequence more
practical for FCD.
5. Conclusion
In conclusion, the FLAWS sequence can help detect epileptogenic
FCD lesions. Diagnosis of the epileptogenic focus should be based on a
combination of two features, one of which is the “blurred junction of
the gray-white matter.” The transmantle sign is not speciﬁc for FCD
type II on FLAWS, indicating that the pathology of the transmantle sign
is more likely related to abnormal cortical layers than dysmorphic
neurons and balloon cells, which may expand the current under-
standing of the imaging criteria and corresponding pathological basis of
FCD.
Supplementary data to this article can be found online at https://
doi.org/10.1016/j.nicl.2018.08.010.
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